Skip to main content
Carolyn McCourt, MD, Obstetrics & Gynecology, Saint Louis, MO, Barnes-Jewish Hospital

CarolynKMcCourtMD

Obstetrics & Gynecology Saint Louis, MO

Gynecologic Oncology

Assistant Professor, Obstetrics and Gynecology, Brown University Program in Medicine

Dr. McCourt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. McCourt's full profile

Already have an account?

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Obstetrics and Gynecology, 2001 - 2005
  • Creighton University School of Medicine
    Creighton University School of MedicineClass of 2001

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2020 - 2026
  • MO State Medical License
    MO State Medical License 2014 - 2025
  • RI State Medical License
    RI State Medical License 2005 - 2016
  • MA State Medical License
    MA State Medical License 2008 - 2014
  • CT State Medical License
    CT State Medical License 2008 - 2014
  • American Board of Obstetrics and Gynecology Obstetrics & Gynecology
  • American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

  • Fellow (FACS) American College of Surgeons
  • Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Therapeutic Inhibition of the Receptor Tyrosine Kinase AXL Improves Sensitivity to Platinum and Taxane in Ovarian Cancer  
    Ian S Hagemann, Premal H Thaker, Carolyn K McCourt, Katherine C Fuh, David G Mutch, Andrea R Hagemann, Matthew A Powell, Clinical Cancer Research
  • Inhibition of the Receptor Tyrosine Kinase AXL Restores Paclitaxel Chemosensitivity in Uterine Serous Cancer  
    Ian S Hagemann, Carolyn K McCourt, Matthew A Powell, Premal H Thaker, David G Mutch, Katherine C Fuh, Andrea R Hagemann, Clinical Cancer Research

Press Mentions

  • NCI-MATCH Cancer Trial Finds a Promising Signal for the AKT Inhibitor Ipatasertib
    NCI-MATCH Cancer Trial Finds a Promising Signal for the AKT Inhibitor IpatasertibOctober 26th, 2022

Professional Memberships

Hospital Affiliations